Clal Biotechnology reported ILS3.41M in Sales Revenues for its fiscal quarter ending in December of 2022.





Sales Change Date
aTyr Pharma USD 190K 2.03M Sep/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
RedHill Biopharma USD 1.29M 722K Jun/2024